S2G Investments, LLC → Faeth Therapeutics, Inc. FTH

Stake: — Shares: — Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 2.81

815,587 shares short · -8.4% vs prior

Other 13D/G Filings on Faeth Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-23	SCHEDULE 13G	SUVRETTA CAPITAL MANAGEMENT, LLC	—	—	view →
2023-05-23	SC	Apeiron Investment Group Ltd.	—	—	view →
2022-11-21	SC	Apeiron Investment Group Ltd.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →